DRKS00032184招募中不适用
Multivariate prediction of disease course and progression in multiple sclerosis using imaging, microbiome, and genetic, immunological, and neuropsychological parameters: a multicenter prospective cohort study
Koordinierungsstelle Telemedizin Baden-Württemberg0 个研究点目标入组 300 人开始时间: 2023年8月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Relapsing or primary progressive multiple sclerosis confirmed according to the revised McDonald criteria.
- •- Initial diagnosis or presentation for evaluation of a change in therapy
排除标准
- •- lack of informed consent
- •- concomitant diseases that prevent routine MRI examinations and regular clinical follow-up examinations (implanted devices, claustrophobia, severe psychiatric diseases)
研究者
相似试验
已完成
不适用
Prediction of illness course and outcome in patients with a first episode of psychosisschizophreniaNL-OMON47512niversitair Medisch Centrum Utrecht86
已完成
不适用
Multivariate analysis of predictors for severity of mucosal lesions in patients with gastro-oesophageal reflux symptoms: a clinical, epidemiological and endoscopic surveyGastro-oesophageal Reflux DiseaseOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12609000045213ycomed GmbH (prior Altana Pharma)400
招募中
2 期
Prognostic and effect predictive factors of multimodality treatment for gastric cancerGastric cancerJPRN-UMIN000031060Yokohama Municipal Citizen's Hospital, Division of Gastroenterological Surgery500
招募中
不适用
Observational Study of Prediction of Disease Progress in Patients with Idiopathic CardiomyopathyIdiopathic cardiomyopathyJPRN-UMIN000042099agoya University Graduate School of Medicine300
已完成
不适用
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter StudyThe study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailandhigh risked neuroblastoma,topotecan,induction therapy,treatment response,prognostic factor,treatment-related toxicityTCTR20190602002Phramongkutklao Hospital and College of Medicine107